

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of metanephros development (GO:0072217) | 5.47048815 |
| 2 | positive regulation of male gonad development (GO:2000020) | 5.21363986 |
| 3 | atrioventricular valve morphogenesis (GO:0003181) | 4.97728880 |
| 4 | epithelial cell differentiation involved in kidney development (GO:0035850) | 4.92903329 |
| 5 | blood coagulation, intrinsic pathway (GO:0007597) | 4.82691798 |
| 6 | endothelium development (GO:0003158) | 4.81974157 |
| 7 | endocardial cushion development (GO:0003197) | 4.78325390 |
| 8 | glyoxylate metabolic process (GO:0046487) | 4.74791260 |
| 9 | protein carboxylation (GO:0018214) | 4.69251103 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.69251103 |
| 11 | parturition (GO:0007567) | 4.68989510 |
| 12 | seminiferous tubule development (GO:0072520) | 4.62324020 |
| 13 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.57975060 |
| 14 | metanephric mesenchyme development (GO:0072075) | 4.46021077 |
| 15 | muscle cell fate commitment (GO:0042693) | 4.44339619 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 4.37364277 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.37364277 |
| 18 | mesonephros development (GO:0001823) | 4.27782093 |
| 19 | glomerular basement membrane development (GO:0032836) | 4.26774624 |
| 20 | positive regulation of odontogenesis (GO:0042482) | 4.17997885 |
| 21 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.17003041 |
| 22 | regulation of male gonad development (GO:2000018) | 4.12252988 |
| 23 | regulation of cardioblast differentiation (GO:0051890) | 4.07421192 |
| 24 | kidney mesenchyme development (GO:0072074) | 4.03532076 |
| 25 | negative regulation of hemostasis (GO:1900047) | 3.88977666 |
| 26 | negative regulation of blood coagulation (GO:0030195) | 3.88977666 |
| 27 | cellular response to gonadotropin stimulus (GO:0071371) | 3.88952369 |
| 28 | sulfation (GO:0051923) | 3.78224517 |
| 29 | fibrinolysis (GO:0042730) | 3.77400669 |
| 30 | regulation of female gonad development (GO:2000194) | 3.73882822 |
| 31 | coenzyme catabolic process (GO:0009109) | 3.72365078 |
| 32 | negative regulation of coagulation (GO:0050819) | 3.71309253 |
| 33 | regulation of protein activation cascade (GO:2000257) | 3.70702209 |
| 34 | ethanol oxidation (GO:0006069) | 3.70664258 |
| 35 | regulation of phospholipase A2 activity (GO:0032429) | 3.69177178 |
| 36 | regulation of glomerulus development (GO:0090192) | 3.67834147 |
| 37 | diaphragm development (GO:0060539) | 3.65244114 |
| 38 | L-phenylalanine metabolic process (GO:0006558) | 3.62864810 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.62864810 |
| 40 | drug catabolic process (GO:0042737) | 3.62485726 |
| 41 | blood vessel maturation (GO:0001955) | 3.59195528 |
| 42 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.57964357 |
| 43 | negative regulation of macrophage differentiation (GO:0045650) | 3.56154873 |
| 44 | regulation of complement activation (GO:0030449) | 3.53522035 |
| 45 | arginine metabolic process (GO:0006525) | 3.53471304 |
| 46 | oxidative demethylation (GO:0070989) | 3.51969420 |
| 47 | negative regulation of wound healing (GO:0061045) | 3.47949595 |
| 48 | ethanol metabolic process (GO:0006067) | 3.40235026 |
| 49 | epithelial cell fate commitment (GO:0072148) | 3.29955457 |
| 50 | arginine catabolic process (GO:0006527) | 3.23388068 |
| 51 | deoxyribose phosphate catabolic process (GO:0046386) | 3.17509256 |
| 52 | skeletal muscle organ development (GO:0060538) | 3.15663235 |
| 53 | glycine metabolic process (GO:0006544) | 3.14579828 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 3.14454180 |
| 55 | positive regulation of metanephros development (GO:0072216) | 3.14189438 |
| 56 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.08576255 |
| 57 | muscle hypertrophy in response to stress (GO:0003299) | 3.08576255 |
| 58 | cardiac muscle adaptation (GO:0014887) | 3.08576255 |
| 59 | cofactor catabolic process (GO:0051187) | 3.07543840 |
| 60 | urea metabolic process (GO:0019627) | 3.04567695 |
| 61 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.04323410 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 3.04177554 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.03754186 |
| 64 | lymphangiogenesis (GO:0001946) | 3.03321523 |
| 65 | negative regulation of complement activation (GO:0045916) | 3.02905239 |
| 66 | polyketide metabolic process (GO:0030638) | 3.02862151 |
| 67 | doxorubicin metabolic process (GO:0044598) | 3.02862151 |
| 68 | daunorubicin metabolic process (GO:0044597) | 3.02862151 |
| 69 | plasma membrane fusion (GO:0045026) | 3.02040141 |
| 70 | serine family amino acid catabolic process (GO:0009071) | 3.01087925 |
| 71 | purine ribonucleotide transport (GO:0015868) | 3.00652885 |
| 72 | omega-hydroxylase P450 pathway (GO:0097267) | 2.99262184 |
| 73 | regulation of gonadotropin secretion (GO:0032276) | 2.99231493 |
| 74 | metanephric epithelium development (GO:0072207) | 2.98442258 |
| 75 | cardiac right ventricle morphogenesis (GO:0003215) | 2.98037486 |
| 76 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.96506691 |
| 77 | mRNA cleavage (GO:0006379) | 2.95561862 |
| 78 | activation of protein kinase B activity (GO:0032148) | 2.90625534 |
| 79 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.89488725 |
| 80 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.89148082 |
| 81 | regulation of bile acid biosynthetic process (GO:0070857) | 2.87176774 |
| 82 | alkaloid metabolic process (GO:0009820) | 2.86967605 |
| 83 | bile acid biosynthetic process (GO:0006699) | 2.85382039 |
| 84 | positive regulation of vasculogenesis (GO:2001214) | 2.85093789 |
| 85 | glomerulus development (GO:0032835) | 2.83372258 |
| 86 | negative regulation of kidney development (GO:0090185) | 2.81200590 |
| 87 | positive regulation of urine volume (GO:0035810) | 2.81099889 |
| 88 | negative regulation of protein activation cascade (GO:2000258) | 2.81054753 |
| 89 | urea cycle (GO:0000050) | 2.78561853 |
| 90 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.77307560 |
| 91 | deoxyribonucleotide catabolic process (GO:0009264) | 2.76987637 |
| 92 | complement activation, alternative pathway (GO:0006957) | 2.75295709 |
| 93 | response to follicle-stimulating hormone (GO:0032354) | 2.74670355 |
| 94 | phenylpropanoid metabolic process (GO:0009698) | 2.71323504 |
| 95 | positive regulation of protein kinase C signaling (GO:0090037) | 2.70735830 |
| 96 | embryonic foregut morphogenesis (GO:0048617) | 2.68226813 |
| 97 | epoxygenase P450 pathway (GO:0019373) | 2.68169407 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 2.66918146 |
| 99 | androgen biosynthetic process (GO:0006702) | 2.65798523 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 2.65629717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.48124406 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.34312768 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.02498670 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.66905272 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.12325498 |
| 6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.07388978 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.99573554 |
| 8 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.95900700 |
| 9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.63843912 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.58026087 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.46777334 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.39843178 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37967524 |
| 14 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.35594212 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.24275028 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.23160115 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.21909390 |
| 18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.16880333 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.08592223 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06653595 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.99001180 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90647472 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88728024 |
| 24 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.86648449 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79540553 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78559500 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76219769 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75342255 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.65807014 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58501162 |
| 31 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.51824050 |
| 32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47413249 |
| 33 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.36664835 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31932934 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29158089 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28711787 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26362288 |
| 38 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26115266 |
| 39 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.24858951 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24314613 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23934930 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22891308 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21004558 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20885761 |
| 45 | ERA_21632823_ChIP-Seq_H3396_Human | 1.18160874 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16361455 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15710647 |
| 48 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12525332 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11476908 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11302376 |
| 51 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10487066 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10145814 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09601144 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07967459 |
| 55 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.06157062 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05858289 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05719979 |
| 58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05171586 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04749809 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03769112 |
| 61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02282086 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01391066 |
| 63 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00793229 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00585752 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99563816 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98242828 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98242828 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98235474 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97712248 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.96482147 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94234401 |
| 72 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93323909 |
| 73 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89942421 |
| 74 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89595964 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89162142 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88657570 |
| 77 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88096561 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87242351 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87028590 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86881982 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85104593 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84047762 |
| 83 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82977056 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82922865 |
| 85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.82679752 |
| 86 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.82637438 |
| 87 | P300_27268052_Chip-Seq_Bcells_Human | 0.82577399 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81717274 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81374914 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80642548 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80299714 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.79071551 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76196448 |
| 94 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.76091236 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75726249 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75412350 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.75208390 |
| 98 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.74520852 |
| 99 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74248172 |
| 100 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.73780710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.03095920 |
| 2 | MP0009697_abnormal_copulation | 4.43582394 |
| 3 | MP0002132_abnormal_respiratory_system | 4.02209587 |
| 4 | MP0010386_abnormal_urinary_bladder | 3.96369698 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.88994138 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.69654604 |
| 7 | MP0004272_abnormal_basement_membrane | 3.59087607 |
| 8 | MP0005360_urolithiasis | 3.32695936 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.26708963 |
| 10 | MP0003828_pulmonary_edema | 3.25922629 |
| 11 | MP0009384_cardiac_valve_regurgitation | 2.95921233 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.87795921 |
| 13 | MP0003868_abnormal_feces_composition | 2.47126412 |
| 14 | MP0001661_extended_life_span | 2.44148302 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.29230245 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.24460588 |
| 17 | MP0008004_abnormal_stomach_pH | 2.19725421 |
| 18 | MP0003011_delayed_dark_adaptation | 2.15512324 |
| 19 | MP0005365_abnormal_bile_salt | 2.13750890 |
| 20 | MP0003315_abnormal_perineum_morphology | 2.09098183 |
| 21 | MP0000767_abnormal_smooth_muscle | 1.90338107 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.89745130 |
| 23 | MP0002127_abnormal_cardiovascular_syste | 1.89434510 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.81970058 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.78603218 |
| 26 | MP0009840_abnormal_foam_cell | 1.64595272 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.62578199 |
| 28 | MP0006138_congestive_heart_failure | 1.58223100 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.54051184 |
| 30 | MP0005595_abnormal_vascular_smooth | 1.51827669 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.51602069 |
| 32 | MP0001764_abnormal_homeostasis | 1.49236851 |
| 33 | MP0005410_abnormal_fertilization | 1.42427572 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.41234716 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.37129953 |
| 36 | MP0002160_abnormal_reproductive_system | 1.34097772 |
| 37 | MP0003186_abnormal_redox_activity | 1.31925724 |
| 38 | MP0003724_increased_susceptibility_to | 1.25860109 |
| 39 | MP0001849_ear_inflammation | 1.24279754 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.20561630 |
| 41 | MP0004484_altered_response_of | 1.17454187 |
| 42 | MP0005389_reproductive_system_phenotype | 1.16503842 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.15190321 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.13947298 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.07726734 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.06886361 |
| 47 | MP0005165_increased_susceptibility_to | 1.04424561 |
| 48 | MP0002089_abnormal_postnatal_growth/wei | 1.00549369 |
| 49 | MP0000343_altered_response_to | 1.00380537 |
| 50 | MP0004036_abnormal_muscle_relaxation | 0.99593037 |
| 51 | MP0003252_abnormal_bile_duct | 0.99227208 |
| 52 | MP0000249_abnormal_blood_vessel | 0.98275533 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.94961751 |
| 54 | MP0003195_calcinosis | 0.92215576 |
| 55 | MP0003279_aneurysm | 0.90931545 |
| 56 | MP0005166_decreased_susceptibility_to | 0.86853305 |
| 57 | MP0005620_abnormal_muscle_contractility | 0.86820182 |
| 58 | MP0000678_abnormal_parathyroid_gland | 0.84384118 |
| 59 | MP0003950_abnormal_plasma_membrane | 0.84031221 |
| 60 | MP0002128_abnormal_blood_circulation | 0.82506294 |
| 61 | MP0008872_abnormal_physiological_respon | 0.81535651 |
| 62 | MP0010329_abnormal_lipoprotein_level | 0.80569961 |
| 63 | MP0005409_darkened_coat_color | 0.79615431 |
| 64 | MP0000538_abnormal_urinary_bladder | 0.79167900 |
| 65 | MP0008775_abnormal_heart_ventricle | 0.77495035 |
| 66 | MP0003942_abnormal_urinary_system | 0.77115207 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77056763 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 0.76975481 |
| 69 | MP0003943_abnormal_hepatobiliary_system | 0.76927508 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 0.75435998 |
| 71 | MP0005164_abnormal_response_to | 0.72777384 |
| 72 | MP0002972_abnormal_cardiac_muscle | 0.69969684 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.69935596 |
| 74 | MP0001919_abnormal_reproductive_system | 0.69916665 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.69766296 |
| 76 | MP0001664_abnormal_digestion | 0.69147933 |
| 77 | MP0001756_abnormal_urination | 0.69097762 |
| 78 | MP0003115_abnormal_respiratory_system | 0.69081414 |
| 79 | MP0008874_decreased_physiological_sensi | 0.68544344 |
| 80 | MP0001544_abnormal_cardiovascular_syste | 0.68000967 |
| 81 | MP0005385_cardiovascular_system_phenoty | 0.68000967 |
| 82 | MP0004883_abnormal_blood_vessel | 0.66639876 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.65262790 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.65262790 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.64365077 |
| 86 | MP0005187_abnormal_penis_morphology | 0.64197978 |
| 87 | MP0009764_decreased_sensitivity_to | 0.63253697 |
| 88 | MP0005332_abnormal_amino_acid | 0.62066533 |
| 89 | MP0001614_abnormal_blood_vessel | 0.61218822 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.60561224 |
| 91 | MP0003385_abnormal_body_wall | 0.59820059 |
| 92 | MP0005023_abnormal_wound_healing | 0.56141720 |
| 93 | MP0003091_abnormal_cell_migration | 0.55938624 |
| 94 | MP0009763_increased_sensitivity_to | 0.55164083 |
| 95 | MP0008995_early_reproductive_senescence | 0.53768362 |
| 96 | MP0004085_abnormal_heartbeat | 0.53175512 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.52784380 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.51565128 |
| 99 | MP0002133_abnormal_respiratory_system | 0.51484937 |
| 100 | MP0005388_respiratory_system_phenotype | 0.51484937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gonadal dysgenesis (HP:0000133) | 8.86997343 |
| 2 | Testicular neoplasm (HP:0010788) | 7.34567994 |
| 3 | Mesangial abnormality (HP:0001966) | 6.14578924 |
| 4 | Hypoplastic left heart (HP:0004383) | 6.00867177 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 5.07955055 |
| 6 | Hypoplastic heart (HP:0001961) | 4.81829678 |
| 7 | Anomalous pulmonary venous return (HP:0010772) | 4.66370225 |
| 8 | Protrusio acetabuli (HP:0003179) | 4.42504603 |
| 9 | Sex reversal (HP:0012245) | 4.42100216 |
| 10 | Abnormal sex determination (HP:0012244) | 4.42100216 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.19968271 |
| 12 | Abnormality of the pulmonary veins (HP:0011718) | 4.12211708 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.90643361 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90046349 |
| 15 | Transposition of the great arteries (HP:0001669) | 3.80896145 |
| 16 | Abnormal connection of the cardiac segments (HP:0011545) | 3.80896145 |
| 17 | Abnormal ventriculo-arterial connection (HP:0011563) | 3.80896145 |
| 18 | Hypoplasia of the uterus (HP:0000013) | 3.72643558 |
| 19 | Germ cell neoplasia (HP:0100728) | 3.72537165 |
| 20 | True hermaphroditism (HP:0010459) | 3.56921422 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43360816 |
| 22 | Male pseudohermaphroditism (HP:0000037) | 3.29434891 |
| 23 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.21074716 |
| 24 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.21074716 |
| 25 | Aortic aneurysm (HP:0004942) | 3.20176700 |
| 26 | Menorrhagia (HP:0000132) | 3.18851073 |
| 27 | Joint hemorrhage (HP:0005261) | 3.17121485 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.12762791 |
| 29 | Abnormality of male internal genitalia (HP:0000022) | 3.11992983 |
| 30 | Female pseudohermaphroditism (HP:0010458) | 3.09265713 |
| 31 | Delayed CNS myelination (HP:0002188) | 3.08761398 |
| 32 | Ileus (HP:0002595) | 3.01514679 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.95236204 |
| 34 | Petechiae (HP:0000967) | 2.85653028 |
| 35 | Primary adrenal insufficiency (HP:0008207) | 2.84490334 |
| 36 | Nonimmune hydrops fetalis (HP:0001790) | 2.83472512 |
| 37 | Abnormal pupillary function (HP:0007686) | 2.65707069 |
| 38 | Male infertility (HP:0003251) | 2.64931279 |
| 39 | Bulbar palsy (HP:0001283) | 2.55163678 |
| 40 | Upper motor neuron abnormality (HP:0002127) | 2.49859059 |
| 41 | Abnormality of the peritoneum (HP:0002585) | 2.46024858 |
| 42 | Purpura (HP:0000979) | 2.40401957 |
| 43 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.40047624 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.35923606 |
| 45 | Rimmed vacuoles (HP:0003805) | 2.34942868 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.31601367 |
| 47 | Focal segmental glomerulosclerosis (HP:0000097) | 2.31349323 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.30896951 |
| 49 | Beaking of vertebral bodies (HP:0004568) | 2.27555842 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.22734986 |
| 51 | Aplastic anemia (HP:0001915) | 2.20656232 |
| 52 | Abnormality of dentin (HP:0010299) | 2.19185560 |
| 53 | Glomerulosclerosis (HP:0000096) | 2.15158701 |
| 54 | Portal hypertension (HP:0001409) | 2.11589150 |
| 55 | Thoracic kyphosis (HP:0002942) | 2.10610059 |
| 56 | Complement deficiency (HP:0004431) | 2.07816579 |
| 57 | Preauricular pit (HP:0004467) | 2.02876275 |
| 58 | Periauricular skin pits (HP:0100277) | 2.02876275 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.02871830 |
| 60 | Biconcave vertebral bodies (HP:0004586) | 1.99101610 |
| 61 | Abnormality of the columella (HP:0009929) | 1.97075514 |
| 62 | Abnormality of the hepatic vasculature (HP:0006707) | 1.96136727 |
| 63 | Intrahepatic cholestasis (HP:0001406) | 1.95838970 |
| 64 | Ovarian neoplasm (HP:0100615) | 1.94976093 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 1.94463895 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 1.91447901 |
| 67 | Epistaxis (HP:0000421) | 1.90095714 |
| 68 | Vertebral compression fractures (HP:0002953) | 1.87457818 |
| 69 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.86149095 |
| 70 | Xerostomia (HP:0000217) | 1.85186797 |
| 71 | Hepatocellular necrosis (HP:0001404) | 1.84475597 |
| 72 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80919291 |
| 73 | Hyperlipoproteinemia (HP:0010980) | 1.76463025 |
| 74 | Hypobetalipoproteinemia (HP:0003563) | 1.75582340 |
| 75 | Rickets (HP:0002748) | 1.72423775 |
| 76 | Hepatic necrosis (HP:0002605) | 1.70922385 |
| 77 | Venous insufficiency (HP:0005293) | 1.69134086 |
| 78 | Spinal rigidity (HP:0003306) | 1.64802869 |
| 79 | Right ventricular cardiomyopathy (HP:0011663) | 1.64335983 |
| 80 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.62195698 |
| 81 | Abnormality of the prostate (HP:0008775) | 1.61179874 |
| 82 | Hyperammonemia (HP:0001987) | 1.59355108 |
| 83 | Xanthomatosis (HP:0000991) | 1.59233558 |
| 84 | Abnormality of complement system (HP:0005339) | 1.58520196 |
| 85 | Papilledema (HP:0001085) | 1.58169739 |
| 86 | Abnormality of the frontal sinuses (HP:0002687) | 1.57207701 |
| 87 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.56814500 |
| 88 | Hydroureter (HP:0000072) | 1.56539262 |
| 89 | High anterior hairline (HP:0009890) | 1.56478638 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.56218405 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 1.56218405 |
| 92 | Glycosuria (HP:0003076) | 1.53972293 |
| 93 | Abnormality of urine glucose concentration (HP:0011016) | 1.53972293 |
| 94 | Spondylolisthesis (HP:0003302) | 1.53556415 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.52979077 |
| 96 | High pitched voice (HP:0001620) | 1.52338483 |
| 97 | Osteomalacia (HP:0002749) | 1.52152603 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.52070528 |
| 99 | Shoulder girdle muscle weakness (HP:0003547) | 1.47872124 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 1.47291097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.55924680 |
| 2 | MYLK | 4.09840254 |
| 3 | LMTK2 | 4.01420047 |
| 4 | NME2 | 3.82616607 |
| 5 | KDR | 3.66127449 |
| 6 | PINK1 | 3.07690883 |
| 7 | FLT3 | 2.89891648 |
| 8 | TGFBR1 | 2.06910349 |
| 9 | PKN2 | 2.02012607 |
| 10 | KIT | 1.97455000 |
| 11 | PRKG2 | 1.95662552 |
| 12 | STK38L | 1.88736783 |
| 13 | ARAF | 1.84262115 |
| 14 | LATS1 | 1.79184337 |
| 15 | EPHB1 | 1.73940890 |
| 16 | CDK8 | 1.72557367 |
| 17 | BMPR1B | 1.61493453 |
| 18 | MAP3K1 | 1.57308815 |
| 19 | NEK2 | 1.53193701 |
| 20 | PIM2 | 1.52181786 |
| 21 | TNK2 | 1.51542050 |
| 22 | PTK2B | 1.47748935 |
| 23 | SGK494 | 1.47050160 |
| 24 | SGK223 | 1.47050160 |
| 25 | LATS2 | 1.46465482 |
| 26 | FES | 1.35009063 |
| 27 | MAP2K7 | 1.32477355 |
| 28 | CDK4 | 1.30802804 |
| 29 | MOS | 1.30053431 |
| 30 | TESK2 | 1.29160840 |
| 31 | MAP3K5 | 1.26223344 |
| 32 | MARK3 | 1.24856779 |
| 33 | MAP3K11 | 1.23291639 |
| 34 | SGK2 | 1.22765325 |
| 35 | TAOK2 | 1.22553244 |
| 36 | ERN1 | 1.22403957 |
| 37 | GRK1 | 1.21909300 |
| 38 | TGFBR2 | 1.18610890 |
| 39 | CDK19 | 1.15252921 |
| 40 | EIF2AK3 | 1.13697872 |
| 41 | NEK9 | 1.12229745 |
| 42 | PAK1 | 1.08148474 |
| 43 | TRPM7 | 1.05135679 |
| 44 | BTK | 1.02099920 |
| 45 | OBSCN | 0.99898935 |
| 46 | DAPK3 | 0.98299068 |
| 47 | BCKDK | 0.97147366 |
| 48 | EPHB2 | 0.95238025 |
| 49 | MAP4K2 | 0.95039372 |
| 50 | MAP3K12 | 0.93939677 |
| 51 | ROCK1 | 0.92865549 |
| 52 | MAP2K3 | 0.89954829 |
| 53 | ILK | 0.86890770 |
| 54 | PRKCQ | 0.86309945 |
| 55 | PRPF4B | 0.85125062 |
| 56 | TBK1 | 0.84390106 |
| 57 | PTK2 | 0.81628546 |
| 58 | NUAK1 | 0.80857932 |
| 59 | PDK2 | 0.80161239 |
| 60 | MAPK12 | 0.73566610 |
| 61 | VRK2 | 0.72885237 |
| 62 | MAP3K6 | 0.72032925 |
| 63 | OXSR1 | 0.70267141 |
| 64 | GRK6 | 0.68566189 |
| 65 | NLK | 0.67928441 |
| 66 | PAK2 | 0.63587699 |
| 67 | MELK | 0.61363169 |
| 68 | DYRK2 | 0.61116531 |
| 69 | GRK5 | 0.60617395 |
| 70 | SGK3 | 0.58276484 |
| 71 | TEC | 0.55539065 |
| 72 | ABL2 | 0.55366255 |
| 73 | AKT2 | 0.52726188 |
| 74 | CSNK1G1 | 0.52030465 |
| 75 | ADRBK2 | 0.46989449 |
| 76 | MINK1 | 0.46552919 |
| 77 | ZAP70 | 0.45861667 |
| 78 | JAK3 | 0.44691389 |
| 79 | ADRBK1 | 0.41939195 |
| 80 | TAOK3 | 0.41717255 |
| 81 | AURKA | 0.38784367 |
| 82 | STK38 | 0.37483227 |
| 83 | RET | 0.37021541 |
| 84 | TESK1 | 0.36226535 |
| 85 | RIPK1 | 0.35366847 |
| 86 | BRAF | 0.34487857 |
| 87 | RPS6KA2 | 0.32835917 |
| 88 | PRKG1 | 0.31621770 |
| 89 | PRKACG | 0.30963729 |
| 90 | CDK7 | 0.27329725 |
| 91 | STK3 | 0.26932528 |
| 92 | MAPK15 | 0.26417977 |
| 93 | FGR | 0.24263616 |
| 94 | CDC42BPA | 0.23240455 |
| 95 | AKT3 | 0.23234631 |
| 96 | CDK3 | 0.23020366 |
| 97 | CSNK1G3 | 0.22428412 |
| 98 | PTK6 | 0.22142297 |
| 99 | ROCK2 | 0.21566526 |
| 100 | EGFR | 0.21233837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.74013788 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.69127705 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.51522797 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.40703247 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.39339147 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.03241328 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.00315727 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64737445 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.50120632 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35695967 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.33643449 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17944572 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08737311 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04547936 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01658036 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.95985211 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90767442 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84924869 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.84571617 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.83084084 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.72853410 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72803042 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.69535331 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67471016 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.62647897 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61307229 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.53699032 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51224695 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49207202 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47862162 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47009702 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.46960690 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44011976 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28963048 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26809258 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23806256 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18210309 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13344858 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10945121 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.07023072 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05705308 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03795147 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01223480 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00851693 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84443798 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75278290 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74486177 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70093933 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70076227 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.68335769 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68315118 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67778467 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67262530 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65125381 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64087678 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63261472 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63034780 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63006050 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62289397 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61758271 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61690609 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.60730620 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.58179312 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50310839 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48615455 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.48561088 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48055427 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.47604405 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46293419 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46061457 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45106795 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44810951 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42120974 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39870342 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39274509 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.37999516 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37864306 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37790311 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37518368 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36768404 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34688100 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34248515 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.33270031 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32645288 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.32591084 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31042858 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30945648 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29780249 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29763952 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28998017 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28110398 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22892777 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22624510 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.22213253 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.21716847 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21352859 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21011278 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.19599619 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.18039326 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.13626261 |

